TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9832314
log Bayes Factor = <0.0001
Chromosome 3   position 72,518,040  (GRCh37) Explore rs9832314 on Ensembl!
Variant rs9832314 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum
0.000 0.984 0.016
Y43.3 Other antineoplastic drugs
0.000 0.985 0.015
C78.7 Secondary malignant neoplasm of liver
0.000 0.985 0.015
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.000 0.985 0.015
C78.2 Secondary malignant neoplasm of pleura
0.000 0.987 0.013
C78.0 Secondary malignant neoplasm of lung
0.000 0.989 0.011
C78.4 Secondary malignant neoplasm of small intestine
0.000 0.989 0.011
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.000 0.989 0.011
C78.1 Secondary malignant neoplasm of mediastinum
0.000 0.989 0.011
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.000 0.989 0.011
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.000 0.991 0.009
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.000 0.991 0.009
C79 Secondary malignant neoplasm of other sites
0.000 0.991 0.009
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.000 0.991 0.008
Y43 Primarily systemic agents
0.000 0.992 0.008
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.000 0.992 0.008
R00.0 Tachycardia, unspecified
0.000 0.993 0.007
C80 Malignant neoplasm without specification of site
0.000 0.993 0.007
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.000 0.993 0.007
C76 Malignant neoplasm of other and ill-defined sites
0.000 0.993 0.007
C79.8 Secondary malignant neoplasm of other specified sites
0.000 0.993 0.006
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.000 0.994 0.006
C79.6 Secondary malignant neoplasm of ovary
0.000 0.994 0.006
C79.9 Secondary malignant neoplasm, unspecified site
0.000 0.994 0.006
C79.7 Secondary malignant neoplasm of adrenal gland
0.000 0.994 0.006
C80.9 Malignant neoplasm, unspecified
0.000 0.994 0.006
Y43.9 Primarily systemic agent, unspecified
0.000 0.994 0.006
Y43.8 Other primarily systemic agents, not elsewhere classified
0.000 0.994 0.006
Y43.6 Enzymes, not elsewhere classified
0.000 0.994 0.006
Y43.5 Acidifying and alkalising agents
0.000 0.994 0.006
Y43.2 Antineoplastic natural products
0.000 0.994 0.006
Y43.1 Antineoplastic antimetabolites
0.000 0.994 0.006
Y43.0 Antiallergic and antiemetic drugs
0.000 0.994 0.006
Y43.4 Immunosuppressive agents
0.000 0.994 0.006
C79.2 Secondary malignant neoplasm of skin
0.000 0.994 0.006
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.000 0.995 0.005
C80.0 Malignant neoplasm, primary site unknown, so stated
0.000 0.995 0.005
C76.8 Overlapping lesion of other and ill-defined sites
0.000 0.995 0.005
C76.7 Other ill-defined sites
0.000 0.995 0.005
C76.5 Lower limb
0.000 0.995 0.005
C76.4 Upper limb
0.000 0.995 0.005
C76.3 Pelvis
0.000 0.995 0.005
C76.2 Abdomen
0.000 0.995 0.005
C76.1 Thorax
0.000 0.995 0.005
C76.0 Head, face and neck
0.000 0.995 0.005
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.000 0.996 0.004
N63 Unspecified lump in breast
0.000 0.996 0.004
C77.0 Lymph nodes of head, face and neck
0.000 0.996 0.004
L98.8 Other specified disorders of skin and subcutaneous tissue
0.004 0.996 0.000
N32.3 Diverticulum of bladder
0.004 0.996 0.000
C77.5 Intrapelvic lymph nodes
0.000 0.996 0.004
C19 Malignant neoplasm of rectosigmoid junction
0.000 0.996 0.004
C77.9 Lymph node, unspecified
0.000 0.996 0.003
M65.91 Synovitis and tenosynovitis, unspecified (Shoulder region)
0.000 0.996 0.003
C83.3 Large cell (diffuse)
0.000 0.997 0.003
J90 Pleural effusion, not elsewhere classified
0.000 0.997 0.003
M65.9 Synovitis and tenosynovitis, unspecified
0.000 0.997 0.003
C77.8 Lymph nodes of multiple regions
0.000 0.997 0.003
M65.94 Synovitis and tenosynovitis, unspecified (Hand)
0.000 0.997 0.003
N87.0 Mild cervical dysplasia
0.003 0.997 0.000
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)
0.000 0.997 0.003
C77.2 Intra-abdominal lymph nodes
0.000 0.997 0.003
C77.1 Intrathoracic lymph nodes
0.000 0.997 0.003
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)
0.000 0.997 0.003
Y42.5 Other oestrogens and progestogens
0.000 0.997 0.003
C77.4 Inguinal and lower limb lymph nodes
0.000 0.997 0.003
G82.1 Spastic paraplegia
0.003 0.997 0.000
G82.5 Tetraplegia, unspecified
0.003 0.997 0.000
Y42.7 Androgens and anabolic congeners
0.000 0.997 0.003
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.997 0.003
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)
0.000 0.997 0.003
E28.2 Polycystic ovarian syndrome
0.003 0.997 0.000
M65.99 Synovitis and tenosynovitis, unspecified (Site unspecified)
0.000 0.997 0.002
M65.98 Synovitis and tenosynovitis, unspecified (Other)
0.000 0.997 0.002
M65.95 Synovitis and tenosynovitis, unspecified (Pelvic region and thigh)
0.000 0.997 0.002
M65.90 Synovitis and tenosynovitis, unspecified (Multiple sites)
0.000 0.997 0.002
H65.3 Chronic mucoid otitis media
0.000 0.998 0.002
G82 Paraplegia and tetraplegia
0.002 0.998 0.000
K59.0 Constipation
0.000 0.998 0.002
M65.92 Synovitis and tenosynovitis, unspecified (Upper arm)
0.000 0.998 0.002
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.000 0.998 0.002
I61.9 Intracerebral haemorrhage, unspecified
0.002 0.998 0.000
C18.9 Colon, unspecified
0.000 0.998 0.002
Y42.9 Other and unspecified hormone antagonists
0.000 0.998 0.002
Y42.4 Oral contraceptives
0.000 0.998 0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.998 0.002
Y42.2 Antithyroid drugs
0.000 0.998 0.002
Y42.1 Thyroid hormones and substitutes
0.000 0.998 0.002
Y42.0 Glucocorticoids and synthetic analogs
0.000 0.998 0.002
G82.4 Spastic tetraplegia
0.002 0.998 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.000 0.998 0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.998 0.002
G82.3 Flaccid tetraplegia
0.002 0.998 0.000
G82.0 Flaccid paraplegia
0.002 0.998 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.000 0.998 0.002
I61.5 Intracerebral haemorrhage, intraventricular
0.002 0.998 0.000
Y59 Other and unspecified vaccines and biological substances
0.000 0.998 0.002
Y58 Bacterial vaccines
0.000 0.998 0.002
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.000 0.998 0.002
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.998 0.002
Y53 Agents primarily affecting the gastro-intestinal system
0.000 0.998 0.002
Y50 Central nervous system stimulants, not elsewhere classified
0.000 0.998 0.002
Y48 Anaesthetics and therapeutic gases
0.000 0.998 0.002
Y47 Sedatives, hypnotics and antianxiety drugs
0.000 0.998 0.002
Y46 Antiepileptics and anti-Parkinsonism drugs
0.000 0.998 0.002
Z04.8 Examination and observation for other specified reasons
0.002 0.998 0.000
I61 Intracerebral haemorrhage
0.002 0.998 0.000
I61.3 Intracerebral haemorrhage in brain stem
0.002 0.998 0.000
T92.2 Sequelae of fracture at wrist and hand level
0.002 0.998 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.998 0.002
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.998 0.002
Y57 Other and unspecified drugs and medicaments
0.000 0.998 0.002
Y49 Psychotropic drugs, not elsewhere classified
0.000 0.998 0.002
Y41 Other systemic anti-infectives and antiparasitics
0.000 0.998 0.002
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.000 0.998 0.002
T92.0 Sequelae of open wound of upper limb
0.002 0.998 0.000
T93.8 Sequelae of other specified injuries of lower limb
0.002 0.998 0.000
Y44 Agents primarily affecting blood constituents
0.000 0.998 0.002
N87.1 Moderate cervical dysplasia
0.002 0.998 0.000
Y45.0 Opioids and related analgesics
0.000 0.998 0.002
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.998 0.002
C83.0 Small cell (diffuse)
0.000 0.998 0.002
G82.2 Paraplegia, unspecified
0.002 0.998 0.000
I61.8 Other intracerebral haemorrhage
0.002 0.998 0.000
E28 Ovarian dysfunction
0.002 0.998 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.000 0.998 0.002
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.998 0.002
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.998 0.002
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.000 0.998 0.002
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.998 0.002
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.998 0.002
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.000 0.998 0.002
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.998 0.002
Y51.1 Other parasympathomimetics [cholinergics]
0.000 0.998 0.002
Y51.0 Anticholinesterase agents
0.000 0.998 0.002
T92 Sequelae of injuries of upper limb
0.002 0.998 0.000
Y46.8 Antispasticity drugs
0.000 0.998 0.001
Y46.7 Anti-Parkinsonism drugs
0.000 0.998 0.001
Y46.6 Other and unspecified antiepileptics
0.000 0.998 0.001
Y46.5 Valproic acid
0.000 0.998 0.001
Y46.4 Iminostilbenes
0.000 0.998 0.001
Y46.3 Deoxybarbiturates
0.000 0.998 0.001
Y46.2 Hydantoin derivatives
0.000 0.998 0.001
Y46.1 Oxazolidinediones
0.000 0.998 0.001
Y46.0 Succinimides
0.000 0.998 0.001
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.000 0.998 0.001
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.000 0.998 0.001
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.000 0.998 0.001
Y47.4 Bromine compounds
0.000 0.998 0.001
Y47.3 Paraldehyde
0.000 0.998 0.001
Y47.2 Chloral derivatives
0.000 0.998 0.001
Y47.1 Benzodiazepines
0.000 0.998 0.001
Y47.0 Barbiturates, not elsewhere classified
0.000 0.998 0.001
Y48.5 Therapeutic gases
0.000 0.998 0.001
Y48.4 Anaesthetic, unspecified
0.000 0.998 0.001
Y48.3 Local anaesthetics
0.000 0.998 0.001
Y48.2 Other and unspecified general anaesthetics
0.000 0.998 0.001
Y48.1 Parenteral anaesthetics
0.000 0.998 0.001
Y48.0 Inhaled anaesthetics
0.000 0.998 0.001
Y50.9 Central nervous system stimulant, unspecified
0.000 0.998 0.001
Y50.8 Other central nervous system stimulants
0.000 0.998 0.001
Y50.2 Methylxanthines, not elsewhere classified
0.000 0.998 0.001
Y50.1 Opioid receptor antagonists
0.000 0.998 0.001
Y50.0 Analeptics
0.000 0.998 0.001
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.998 0.001
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.998 0.001
Y53.7 Emetics
0.000 0.998 0.001
Y53.6 Antidiarrhoeal drugs
0.000 0.998 0.001
Y53.5 Digestants
0.000 0.998 0.001
Y53.4 Other laxatives
0.000 0.998 0.001
Y53.3 Saline and osmotic laxatives
0.000 0.998 0.001
Y53.2 Stimulant laxatives
0.000 0.998 0.001
Y53.1 Other antacids and anti-gastric-secretion drugs
0.000 0.998 0.001
Y53.0 Histamine H2-receptor antagonists
0.000 0.998 0.001
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.998 0.001
Y55.6 Antiasthmatics, not elsewhere classified
0.000 0.998 0.001
Y55.5 Anticommon cold drugs
0.000 0.998 0.001
Y55.4 Expectorants
0.000 0.998 0.001
Y55.3 Antitussives
0.000 0.998 0.001
Y55.2 Other and unspecified agents primarily acting on muscles
0.000 0.998 0.001
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.998 0.001
Y55.0 Oxytocic drugs
0.000 0.998 0.001
Y56.9 Topical agent, unspecified
0.000 0.998 0.001
Y56.8 Other topical agents
0.000 0.998 0.001
Y56.7 Dental drugs, topically applied
0.000 0.998 0.001
Y56.6 Otorhinolaryngological drugs and preparations
0.000 0.998 0.001
Y56.5 Ophthalmological drugs and preparations
0.000 0.998 0.001
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.998 0.001
Y56.3 Emollients, demulcents and protectants
0.000 0.998 0.001
Y56.2 Local astringents and local detergents
0.000 0.998 0.001
Y56.1 Antipruritics
0.000 0.998 0.001
Y58.9 Other and unspecified bacterial vaccines
0.000 0.998 0.001
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.000 0.998 0.001
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.000 0.998 0.001
Y58.5 Diphtheria vaccine
0.000 0.998 0.001
Y58.4 Tetanus vaccine
0.000 0.998 0.001
Y58.3 Plague vaccine
0.000 0.998 0.001
Y58.2 Cholera vaccine
0.000 0.998 0.001
Y58.1 Typhoid and paratyphoid vaccine
0.000 0.998 0.001
Y58.0 BCG vaccine
0.000 0.998 0.001
Y59.9 Vaccine or biological substance, unspecified
0.000 0.998 0.001
Y59.8 Other specified vaccines and biological substances
0.000 0.998 0.001
Y59.3 Immunoglobulin
0.000 0.998 0.001
Y59.2 Protozoal vaccines
0.000 0.998 0.001
Y59.1 Rickettsial vaccines
0.000 0.998 0.001
Y59.0 Viral vaccines
0.000 0.998 0.001
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.998 0.001
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.998 0.001
C83.7 Burkitt's tumour
0.000 0.998 0.001
C83.6 Undifferentiated (diffuse)
0.000 0.998 0.001
C83.5 Lymphoblastic (diffuse)
0.000 0.998 0.001
C83.4 Immunoblastic (diffuse)
0.000 0.998 0.001
C83.2 Mixed small and large cell (diffuse)
0.000 0.998 0.001
C83.1 Small cleaved cell (diffuse)
0.000 0.998 0.001
I61.6 Intracerebral haemorrhage, multiple localised
0.002 0.998 0.000
I61.4 Intracerebral haemorrhage in cerebellum
0.002 0.998 0.000
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.002 0.998 0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.002 0.998 0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.002 0.998 0.000
R82.9 Other and unspecified abnormal finding in urine
0.002 0.998 0.000
Y40 Systemic antibiotics
0.000 0.998 0.002
H74.4 Polyp of middle ear
0.002 0.998 0.000
Y57.8 Other drugs and medicaments
0.000 0.998 0.001
Y57.7 Vitamins, not elsewhere classified
0.000 0.998 0.001
Y57.6 Other diagnostic agents
0.000 0.998 0.001
Y57.5 X-ray contrast media
0.000 0.998 0.001
Y57.4 Pharmaceutical excipients
0.000 0.998 0.001
Y57.3 Alcohol deterrents
0.000 0.998 0.001
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.000 0.998 0.001
Y57.1 Lipotropic drugs
0.000 0.998 0.001
Y57.0 Appetite depressants [anorectics]
0.000 0.998 0.001
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.998 0.001
Y41.5 Antiviral drugs
0.000 0.998 0.001
Y41.4 Anthelminthics
0.000 0.998 0.001
Y41.3 Other antiprotozoal drugs
0.000 0.998 0.001
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.998 0.001
Y41.1 Antimycobacterial drugs
0.000 0.998 0.001
Y41.0 Sulphonamides
0.000 0.998 0.001
Y49.9 Psychotropic drug, unspecified
0.000 0.998 0.001
Y49.8 Other psychotropic drugs, not elsewhere classified
0.000 0.998 0.001
Y49.7 Psychostimulants with abuse potential
0.000 0.998 0.001
Y49.6 Psychodysleptics [hallucinogens]
0.000 0.998 0.001
Y49.5 Other antipsychotics and neuroleptics
0.000 0.998 0.001
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.998 0.001
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.998 0.001
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.998 0.001
Y49.0 Tricyclic and tetracyclic antidepressants
0.000 0.998 0.001
D12.8 Rectum
0.002 0.998 0.000
H74.2 Discontinuity and dislocation of ear ossicles
0.001 0.998 0.000
Y54.9 Mineral salts, not elsewhere classified
0.000 0.998 0.001
Y54.8 Agents affecting uric acid metabolism
0.000 0.998 0.001
Y54.7 Agents affecting calcification
0.000 0.998 0.001
Y54.6 Electrolytic, caloric and water-balance agents
0.000 0.998 0.001
Y54.4 Loop [high-ceiling] diuretics
0.000 0.998 0.001
Y54.2 Carbonic-anhydrase inhibitors
0.000 0.998 0.001
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.000 0.998 0.001
Y54.0 Mineralocorticoids
0.000 0.998 0.001
T94.1 Sequelae of injuries, not specified by body region
0.001 0.998 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.000 0.998 0.001
Y44.7 Plasma substitutes
0.000 0.998 0.001
Y44.6 Natural blood and blood products
0.000 0.998 0.001
Y44.5 Thrombolytic drugs
0.000 0.998 0.001
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.000 0.998 0.001
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.998 0.001
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.000 0.998 0.001
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.000 0.998 0.001
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.998 0.001
Y45.8 Other analgesics and antipyretics
0.000 0.998 0.001
Y45.5 4-Aminophenol derivatives
0.000 0.998 0.001
Y45.4 Antirheumatics
0.000 0.998 0.001
H74 Other disorders of middle ear and mastoid
0.002 0.998 0.000
H74.9 Disorder of middle ear and mastoid, unspecified
0.001 0.998 0.000
N87 Dysplasia of cervix uteri
0.002 0.998 0.000
H74.0 Tympanosclerosis
0.001 0.998 0.000
Y52 Agents primarily affecting the cardiovascular system
0.000 0.998 0.001
E28.9 Ovarian dysfunction, unspecified
0.001 0.998 0.000
E28.8 Other ovarian dysfunction
0.001 0.998 0.000
E28.3 Primary ovarian failure
0.001 0.998 0.000
E28.1 Androgen excess
0.001 0.998 0.000
E28.0 Oestrogen excess
0.001 0.998 0.000
Y54.3 Benzothiadiazine derivatives
0.000 0.998 0.001
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.998 0.001
T92.8 Sequelae of other specified injuries of upper limb
0.001 0.998 0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb
0.001 0.998 0.000
T92.4 Sequelae of injury of nerve of upper limb
0.001 0.998 0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb
0.001 0.998 0.000
Y45.2 Propionic acid derivatives
0.000 0.998 0.001
R82.8 Abnormal findings on cytological and histological examination of urine
0.001 0.999 0.000
T92.9 Sequelae of unspecified injury of upper limb
0.001 0.999 0.000
Y45.1 Salicylates
0.000 0.999 0.001
Y57.9 Drug or medicament, unspecified
0.000 0.999 0.001
N28.9 Disorder of kidney and ureter, unspecified
0.001 0.999 0.000
N92.3 Ovulation bleeding
0.000 0.999 0.001
M80.98 Unspecified osteoporosis with pathological fracture (Other)
0.000 0.999 0.001
D09.0 Bladder
0.001 0.999 0.000
H83.0 Labyrinthitis
0.001 0.999 0.000
Y40.7 Antifungal antibiotics, systemically used
0.000 0.999 0.001
Y40.6 Rifamycins
0.000 0.999 0.001
Y40.5 Aminoglycosides
0.000 0.999 0.001
Y40.4 Tetracyclines
0.000 0.999 0.001
Y40.3 Macrolides
0.000 0.999 0.001
Y40.2 Chloramphenicol group
0.000 0.999 0.001
Y40.1 Cefalosporins and other -lactam antibiotics
0.000 0.999 0.001
Y49.2 Other and unspecified antidepressants
0.000 0.999 0.001
H81.2 Vestibular neuronitis
0.001 0.999 0.000
K50.0 Crohn's disease of small intestine
0.000 0.999 0.001
T91.3 Sequelae of injury of spinal cord
0.001 0.999 0.000
T92.1 Sequelae of fracture of arm
0.001 0.999 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.999 0.001
Y54.5 Other diuretics
0.000 0.999 0.001
T94 Sequelae of injuries involving multiple and unspecified body regions
0.001 0.999 0.000
E22.0 Acromegaly and pituitary gigantism
0.001 0.999 0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb
0.001 0.999 0.000
Y40.0 Penicillins
0.000 0.999 0.001
T91 Sequelae of injuries of neck and trunk
0.001 0.999 0.000
H74.3 Other acquired abnormalities of ear ossicles
0.001 0.999 0.000
H74.1 Adhesive middle ear disease
0.001 0.999 0.000
N87.2 Severe cervical dysplasia, not elsewhere classified
0.001 0.999 0.000
H74.8 Other specified disorders of middle ear and mastoid
0.001 0.999 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.999 0.001
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.999 0.001
Y52.7 Peripheral vasodilators
0.000 0.999 0.001
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.999 0.001
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.999 0.001
L81.4 Other melanin hyperpigmentation
0.001 0.999 0.000
T91.8 Sequelae of other specified injuries of neck and trunk
0.001 0.999 0.000
Y44.2 Anticoagulants
0.000 0.999 0.001
R82 Other abnormal findings in urine
0.001 0.999 0.000
S72.00 Fracture of neck of femur (closed)
0.001 0.999 0.000
Z80.3 Family history of malignant neoplasm of breast
0.000 0.999 0.001
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.001 0.999 0.000
T93 Sequelae of injuries of lower limb
0.001 0.999 0.000
C18.5 Splenic flexure
0.000 0.999 0.001
R82.7 Abnormal findings on microbiological examination of urine
0.001 0.999 0.000
T94.0 Sequelae of injuries involving multiple body regions
0.001 0.999 0.000
T98.1 Sequelae of other and unspecified effects of external causes
0.001 0.999 0.000
Y40.9 Systemic antibiotic, unspecified
0.000 0.999 0.001
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.999 0.001
T98 Sequelae of other and unspecified effects of external causes
0.001 0.999 0.000
E21.3 Hyperparathyroidism, unspecified
0.001 0.999 0.000
T91.9 Sequelae of unspecified injury of neck and trunk
0.001 0.999 0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs
0.001 0.999 0.000
T91.4 Sequelae of injury of intrathoracic organs
0.001 0.999 0.000
T91.2 Sequelae of other fracture of thorax and pelvis
0.001 0.999 0.000
T91.1 Sequelae of fracture of spine
0.001 0.999 0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk
0.001 0.999 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.000 0.999 0.001
Y52.1 Calcium-channel blockers
0.000 0.999 0.001
R00 Abnormalities of heart beat
0.000 0.999 0.001
C26.0 Intestinal tract, part unspecified
0.000 0.999 0.001
Y40.8 Other systemic antibiotics
0.000 0.999 0.001
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.999 0.001
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.999 0.001
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source
0.001 0.999 0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances
0.001 0.999 0.000
R82.4 Acetonuria
0.001 0.999 0.000
R82.3 Haemoglobinuria
0.001 0.999 0.000
R82.2 Biliuria
0.001 0.999 0.000
R82.1 Myoglobinuria
0.001 0.999 0.000
R82.0 Chyluria
0.001 0.999 0.000
K59.8 Other specified functional intestinal disorders
0.000 0.999 0.001
N21.0 Calculus in bladder
0.001 0.999 0.000
R00.8 Other and unspecified abnormalities of heart beat
0.000 0.999 0.001
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb
0.001 0.999 0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb
0.001 0.999 0.000
T93.4 Sequelae of injury of nerve of lower limb
0.001 0.999 0.000
T93.0 Sequelae of open wound of lower limb
0.001 0.999 0.000
T95 Sequelae of burns, corrosions and frostbite
0.001 0.999 0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source
0.001 0.999 0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances
0.001 0.999 0.000
F00.9 Dementia in Alzheimer's disease, unspecified
0.001 0.999 0.000
H01.0 Blepharitis
0.001 0.999 0.000
T98.2 Sequelae of certain early complications of trauma
0.001 0.999 0.000
T98.0 Sequelae of effects of foreign body entering through natural orifice
0.001 0.999 0.000
Z73.9 Problem related to life-management difficulty, unspecified
0.001 0.999 0.000
T93.1 Sequelae of fracture of femur
0.001 0.999 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.000 0.999 0.001
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.999 0.001
H83 Other diseases of inner ear
0.001 0.999 0.000
S42.10 Fracture of scapula (closed)
0.000 0.999 0.001
K59.9 Functional intestinal disorder, unspecified
0.000 0.999 0.001
T98.3 Sequelae of complications of surgical and medical care, not elsewhere classified
0.001 0.999 0.000
C18 Malignant neoplasm of colon
0.000 0.999 0.001
C15.5 Lower third of oesophagus
0.000 0.999 0.001
T93.9 Sequelae of unspecified injury of lower limb
0.001 0.999 0.000
C20 Malignant neoplasm of rectum
0.000 0.999 0.001
E22 Hyperfunction of pituitary gland
0.001 0.999 0.000
K59 Other functional intestinal disorders
0.000 0.999 0.001
C77.3 Axillary and upper limb lymph nodes
0.000 0.999 0.001
K01.1 Impacted teeth
0.000 0.999 0.001
S43.0 Dislocation of shoulder joint
0.000 0.999 0.001
T95.9 Sequelae of unspecified burn, corrosion and frostbite
0.001 0.999 0.000
T95.8 Sequelae of other specified burn, corrosion and frostbite
0.001 0.999 0.000
T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved
0.001 0.999 0.000
T95.3 Sequelae of burn, corrosion and frostbite of lower limb
0.001 0.999 0.000
T95.2 Sequelae of burn, corrosion and frostbite of upper limb
0.001 0.999 0.000
T95.1 Sequelae of burn, corrosion and frostbite of trunk
0.001 0.999 0.000
T95.0 Sequelae of burn, corrosion and frostbite of head and neck
0.001 0.999 0.000
C26.9 Ill-defined sites within the digestive system
0.000 0.999 0.001
C26.8 Overlapping lesion of digestive system
0.000 0.999 0.001
C26.1 Spleen
0.000 0.999 0.001
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.999 0.001
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.999 0.001
C85.0 Lymphosarcoma
0.000 0.999 0.001
H83.9 Disease of inner ear, unspecified
0.001 0.999 0.000
H83.8 Other specified diseases of inner ear
0.001 0.999 0.000
H83.3 Noise effects on inner ear
0.001 0.999 0.000
H83.2 Labyrinthine dysfunction
0.001 0.999 0.000
H83.1 Labyrinthine fistula
0.001 0.999 0.000
K59.3 Megacolon, not elsewhere classified
0.000 0.999 0.001
R22.2 Localised swelling, mass and lump, trunk
0.000 0.999 0.001
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.999 0.001
Z71.9 Counselling, unspecified
0.001 0.999 0.000
C18.8 Overlapping lesion of colon
0.000 0.999 0.001
K59.2 Neurogenic bowel, not elsewhere classified
0.000 0.999 0.001
C15-C26 Malignant neoplasms of digestive organs
0.000 0.999 0.001
C18.6 Descending colon
0.000 0.999 0.001
C25.0 Head of pancreas
0.000 0.999 0.001
E22.9 Hyperfunction of pituitary gland, unspecified
0.001 0.999 0.000
E22.8 Other hyperfunction of pituitary gland
0.001 0.999 0.000
E22.1 Hyperprolactinaemia
0.001 0.999 0.000
H81.1 Benign paroxysmal vertigo
0.001 0.999 0.000
H65 Nonsuppurative otitis media
0.001 0.999 0.001
S12.00 Fracture of first cervical vertebra (closed)
0.001 0.999 0.000
C44.7 Skin of lower limb, including hip
0.001 0.999 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.001 0.999 0.000
F01.9 Vascular dementia, unspecified
0.001 0.999 0.000
Q23.1 Congenital insufficiency of aortic valve
0.000 0.999 0.001
Q89.2 Congenital malformations of other endocrine glands
0.001 0.999 0.000
T93.2 Sequelae of other fractures of lower limb
0.001 0.999 0.000
C25 Malignant neoplasm of pancreas
0.000 0.999 0.001
M65 Synovitis and tenosynovitis
0.000 0.999 0.001
M00.94 Pyogenic arthritis, unspecified (Hand)
0.001 0.999 0.000
C18.0 Caecum
0.000 0.999 0.001
C85.1 B-cell lymphoma, unspecified
0.000 0.999 0.001
F00.0 Dementia in Alzheimer's disease with early onset
0.001 0.999 0.000
C23 Malignant neoplasm of gallbladder
0.000 0.999 0.001
H81 Disorders of vestibular function
0.001 0.999 0.000
C25.8 Overlapping lesion of pancreas
0.000 0.999 0.001
C25.7 Other parts of pancreas
0.000 0.999 0.001
C25.4 Endocrine pancreas
0.000 0.999 0.001
C25.3 Pancreatic duct
0.000 0.999 0.001
C25.2 Tail of pancreas
0.000 0.999 0.001
C25.1 Body of pancreas
0.000 0.999 0.001
E34.8 Other specified endocrine disorders
0.001 0.999 0.000
H65.1 Other acute nonsuppurative otitis media
0.001 0.999 0.001
H65.0 Acute serous otitis media
0.001 0.999 0.001
M65.2 Calcific tendinitis
0.000 0.999 0.001
M65.1 Other infective (teno)synovitis
0.000 0.999 0.001
M65.0 Abscess of tendon sheath
0.000 0.999 0.001
Z34.0 Supervision of normal first pregnancy
0.000 0.999 0.001
T90 Sequelae of injuries of head
0.001 0.999 0.000
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)
0.001 0.999 0.000
M89.94 Disorder of bone, unspecified (Hand)
0.001 0.999 0.000
C18.1 Appendix
0.000 0.999 0.001
D73.0 Hyposplenism
0.000 0.999 0.001
H40.0 Glaucoma suspect
0.001 0.999 0.000
H81.9 Disorder of vestibular function, unspecified
0.001 0.999 0.000
H81.8 Other disorders of vestibular function
0.001 0.999 0.000
H81.4 Vertigo of central origin
0.001 0.999 0.000
H81.3 Other peripheral vertigo
0.001 0.999 0.000
K70.9 Alcoholic liver disease, unspecified
0.001 0.999 0.000
T90.8 Sequelae of other specified injuries of head
0.001 0.999 0.000
T90.5 Sequelae of intracranial injury
0.001 0.999 0.000
T90.3 Sequelae of injury of cranial nerves
0.001 0.999 0.000
T90.2 Sequelae of fracture of skull and facial bones
0.001 0.999 0.000
T90.1 Sequelae of open wound of head
0.001 0.999 0.000
T90.0 Sequelae of superficial injury of head
0.001 0.999 0.000
Z86.1 Personal history of infectious and parasitic diseases
0.000 0.999 0.001
H71 Cholesteatoma of middle ear
0.001 0.999 0.000
M65.09 Abscess of tendon sheath (Site unspecified)
0.000 0.999 0.001
M65.08 Abscess of tendon sheath (Other)
0.000 0.999 0.001
M65.07 Abscess of tendon sheath (Ankle and foot)
0.000 0.999 0.001
M65.06 Abscess of tendon sheath (Lower leg)
0.000 0.999 0.001
M65.05 Abscess of tendon sheath (Pelvic region and thigh)
0.000 0.999 0.001
M65.04 Abscess of tendon sheath (Hand)
0.000 0.999 0.001
M65.03 Abscess of tendon sheath (Forearm)
0.000 0.999 0.001
M65.02 Abscess of tendon sheath (Upper arm)
0.000 0.999 0.001
M65.01 Abscess of tendon sheath (Shoulder region)
0.000 0.999 0.001
M65.00 Abscess of tendon sheath (Multiple sites)
0.000 0.999 0.001
M65.19 Other infective (teno)synovitis (Site unspecified)
0.000 0.999 0.001
M65.18 Other infective (teno)synovitis (Other)
0.000 0.999 0.001
M65.17 Other infective (teno)synovitis (Ankle and foot)
0.000 0.999 0.001
M65.16 Other infective (teno)synovitis (Lower leg)
0.000 0.999 0.001
M65.15 Other infective (teno)synovitis (Pelvic region and thigh)
0.000 0.999 0.001
M65.14 Other infective (teno)synovitis (Hand)
0.000 0.999 0.001
M65.13 Other infective (teno)synovitis (Forearm)
0.000 0.999 0.001
M65.12 Other infective (teno)synovitis (Upper arm)
0.000 0.999 0.001
M65.11 Other infective (teno)synovitis (Shoulder region)
0.000 0.999 0.001
M65.10 Other infective (teno)synovitis (Multiple sites)
0.000 0.999 0.001
M65.29 Calcific tendinitis (Site unspecified)
0.000 0.999 0.001
M65.28 Calcific tendinitis (Other)
0.000 0.999 0.001
M65.27 Calcific tendinitis (Ankle and foot)
0.000 0.999 0.001
M65.26 Calcific tendinitis (Lower leg)
0.000 0.999 0.001
M65.25 Calcific tendinitis (Pelvic region and thigh)
0.000 0.999 0.001
M65.24 Calcific tendinitis (Hand)
0.000 0.999 0.001
M65.23 Calcific tendinitis (Forearm)
0.000 0.999 0.001
M65.22 Calcific tendinitis (Upper arm)
0.000 0.999 0.001
M65.21 Calcific tendinitis (Shoulder region)
0.000 0.999 0.001
M65.20 Calcific tendinitis (Multiple sites)
0.000 0.999 0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.